General Child Neurology
Congenital heart disease: neurologic complications
Mar. 29, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Bound cobalamin (CN-cbl, OH-CBL) is transported from the phagolysosomal compartment after release from transcobalamin 2. The central cobalt atom likely undergoes reductive processing after export into the cytosol. The reduced cobalamin species, designated Cbl(II) in the diagram, is transported across the outer and inner mitochondrial membranes and enters the matrix, where it is converted into adenosylcobalamin, the cofactor required for the methylmalonyl-CoA mutase reaction. The complementation class and genes known to be associated with isolated methylmalonic acidemia are: cblA (MMAA); cblB (MMAB); cblD variant 2; mut (L-methylmalonyl-CoA mutase). Combined homocysteinemia/methylmalonic acidemia is caused by: cblC deficiency (MMACHC); cblD deficiency, unknown gene(s); cblF deficiency, unknown gene. Steps that affect only the synthesis of methylcobalamin and cause homocysteinemia without methylmalonic aciduria; cblE deficiency, methionine synthase reductase; cblG deficiency, methionine synthase; cblD variant 1 deficiency, unknown gene. The cblH is allelic to cblD variant 2. The precise location of the cblD variant 1 and variant 2 steps are uncertain. (Contributed by Dr. Gerard Berry.)